Childress, Scott J. published the artcileElectronegative substitutions in local anesthetics of the benzoic acid ester type, Computed Properties of 5204-46-6, the publication is Journal of the American Chemical Society (1954), 3988-91, database is CAplus.
A series of substituted BzOH esters of various alkanolamines has been prepared and tested pharmacologically. Esters of the tertiary amino alcs. were prepared either by the condensation of the corresponding dialkylaminoalkyl chloride with the Na salt of the acid (method A) or by the condensation of the acid chloride with the amino alc. in the presence of excess base (method B). The esters of secondary amines were prepared by refluxing the HCl salt of the secondary amino alc. with the acid chloride (method C). The nitro esters were reduced to the amino esters by treating the HCl salts with Fe powder in H2O or aqueous EtOH (method D). The topical and intradermal anesthetic activities of the resulting esters were measured on guinea pig wheal and rabbit cornea, resp.; comparisons were made with cocaine or procaine, to each of which the value 1 was assigned; the acute toxicities were determined in albino mice. Me3CNH2 (37 g.), 22 g. ethylene oxide, and 2 cc. MeOH refrigerated 3 days and the mixture fractionated gave 6.5 g. Me3CNH(CH2)2OH, b. 176-7°; picrate, m. 159-60° (from H2O). 2,4-Cl(H2N)C6H3CO2H (34.3 g.), 30 g. BuBr, and 13.2 g. KOH in 250 cc. 75% EtOH refluxed overnight, the mixture treated with 13.2 g. KOH and 30 g. BuBr, refluxed 8 hrs., concentrated in vacuo, made basic with KOH, extracted with Et2O, and acidified, the solid precipitate (20 g.) extracted with 3 l. boiling H2O, the solution let stand, the procedure repeated with the mother liquor, and the resulting crystals recrystallized 3 times from 95% EtOH yielded 7.5 g. 2,4-Cl(BuNH)C6H3CO2H (I), white crystals, m. 112-14°; the residue from the H2O extraction recrystallized twice from absolute EtOH gave 2,4-Cl(Bu2N)C6H3CO2H, white crystals, m. 127-9°. 2,6,4-Cl2(O2N)C6H2Me (12 g.) in 50 cc. pyridine and 40 cc. H2O, the mixture heated to the b.p., treated at intervals with six 4.3-g. portions KMnO4, and filtered, the filtrate concentrated in vacuo to 1/4 its original volume and treated with concentrated HCl, the precipitate dissolved in aqueous NaOH to remove 6 g. unreacted material, the solution acidified, and the yellow crystalline precipitate (2 g.) repeatedly recrystallized from H2O and dried gave 2,6,4-Cl2(O2N)C6H2CO2H (II), white crystals, m. 172-4° with sintering at 157°. II (7 g.) refluxed 4 hrs. with 25 g. SOCl2, and the resulting crude acid chloride treated with EtOH gave a poor yield of the Et ester, but yielded some anhydride of II, yellow needles, m. 190-1.5° (from EtOH). II (1.9 g.) and 1.5 g. 5% Pd-C added to 60 cc. MeOH, the mixture treated with stirring during 5 min. with 1 g. N2H4 in 5 cc. MeOH, let stand over the weekend, filtered, concentrated to 10 cc., poured into 25 cc. H2O, and acidified, and the precipitate recrystallized twice from H2O yielded 0.4 g. 2,6,4-Cl2(H2N)C6H2CO2H (III), cream-colored crystals, m. 178-9° (decomposition). The following alkyl ester of ο-ClC6H4CO2H HCl salts [alkyl group, m.p., method of preparation, local anesthetic activity compared to cocaine (topical) and procaine (intradermal), and the subcutaneous and the intravenous LD50 in mg./kg. given] were prepared: Et2N(CH2)2, 127-8° (from 95% EtOH), A, 0, 0.4, >1000, 120; Me2CHCH2NH(CH2)2, 141-2° (from EtOH-Et2O), C, 0, 1.5, >1000, 75; EtMeCHNH(CH2)2, 181-3° (95% EtOH), C, 0, 1.2, >1000, 91; β-cyclohexylaminoethyl, 203-5° (from 50% EtOH), C, 0.3, 1,2, >1000, 98; β-cyclohexylaminoisopropyl, 174-5°, C, 1.7, 1.1, 250, 36. The following ester HCl salts of 3,4-Cl2C6H4CO2H (same data given): Et2N(CH2)2, 178.5-80° (from EtOAc-EtOH), B, 0, 0.6, 840, 84; EtMeCHNH(CH2)2, 180-2° (from 95% EtOH), C, 0.3, 0.8, 510, 120. The following ester HCl salts of 2,4-Cl(O2N)C6H3CO2H (m.p. and method given): Et2NCHMeCH2, 150.5-2.5°, B; Et2NCH2CHMe, 145-8° (from EtOH-Et2O), B; Et2N(CH2)3, 125-6° (from EtOH-Et2O), B; Me2CHNH(CH2)2, 188-9°, C; BuNH(CH2)2, 162-3.5°, C; Me2CHCH2NH(CH2)2, 172-4°, C; EtMeCHNH(CH2)2, 160-1°, C; Me3CNH(CH2)2, 190-2°, C; Et2CHNH(CH2)2, 162-4°, C; BuNH(CH2)3, 140-1°, C; EtMeCHNH(CH2)3, 160-3°, C; β-cyclohexylaminoethyl, 177-8°, C; 2-cyclohexylamino-1-propyl, 179-80.5°, C; 1-cyclohexyl-2-propyl, 171-2.5°, C; β-cyclohexylaminoisopropyl, 182.5-84°, C; 2-cyclohexylamino-1-phenylethyl, 196-8°, C. 2,4-Br(O2N)C6H3CO2(CH2)2NHCHEtMe.HCl, 157-8°, C. 2,4-(O2N)2C6H3CO2(CH2)2NEt2, 137-9° (from EtOH-Et2O), B (all nitro esters, except where otherwise stated, were recrystallized from EtOH). The following alkyl ester HCl salts of 2,4-Cl(H2N)C6H3CO2H (all by method D) (alkyl group, m.p., activity, and toxicity given): Et2NCHMeCH2, 156.5-7.5° (from EtOH-EtOAc), 1.1, 2.2, 240, 44; Et2NCH2CHMe, 156-7°, 1.3, 3.1, 220, 55; Et2N(CH2)3, 198.5-9.5°, 2.9, 2.5, 205, 50; Me2CHNH(CH2)2(HCO2H salt), 163-5°, 0.9, 1.0, 900, 84; BuNH(CH2)2, 161-3°, 0.9, 6.0, 320, 47; Me2CHCH2NH(CH2)2, 215-17°, 1.3, 4.4, 260, 50; EtMeCHNH(CH2)2, 195.5-97°, 2.6, 4.1, 570, 45; (HCO2H salt), 152-2.5°, 2.3, 4.9, 670, 46) [0.5(CH2CO2H)2 salt], 192-4°, -, 4.9, -, -]; Me2CHNH(CH2)2, 270° (decomposition), 1.0, 1.0, 750, 63; Et2CHNH(CH2)2(HCO2H salt), 145-6.5°, 1.9, 1.3, 740, 37; BuNH(CH2)3, 168-70°, 1.8, 3.1, 140, 23; EtMeCH(CH2)3, 208-9.5°, 2.7, 1.4, 220, 29; β-cyclohexylaminoethyl, 224.5-26°, 2.4, 3.1, 280, 29; 2-cyclohexylaminopropyl (HCO2H salt), 162.5-64°, 3.0, 2.1, 330, 24; β-cyclohexylamino-2-propyl, 159-61°, 3.4, 3.1, 57, 17; 3-cyclohexylaminoisopropyl, 188.5-9.5°, 2.2, 3.4, 120, 17; 2-cyclohexylamino-1-phenylethyl, 239-41° (decomposition), -, -, -, -; 2,4-Br(H2N)C6H3CO2(CH2)2NHCHEtMe, 202-4°, 2.5, 2.7, 450, 43. The following ester HCl salts of 4,2-H2N(O2N)C6H3CO2H by method A (same data given): Et2N(CH2)2, 177-9°, 0.2, 1.4, 850, 130; Et2NCHMeCH2, 182-5°, 0, 1.5, 800, 71; Et2N(CH2)3, 221-3°, 0.5, 1.0, 430, 49. The following ester salts of I (same data given) by method A: Me2N(CH2)2 HCl salt monohydrate, 84-6° (from EtOH-EtOAc), 0.1, 1.9, 1000, 72; Me2N(CH2)2 di-HCl salt, 167-70° (decomposition), -, -, -, -; Et2N(CH2)2 di-HCl salt, 151-4°, -, -, -, – (all previous ester salts were recrystallized from EtOH, except where otherwise indicated). The Et2N(CH2)2 ester HCl salts of the following acids (m.p., method, activity, and toxicity given): 2,5-Cl(O2N)C6H3CO2H, 197-8° (from EtOH), B, -, -, -, -; 2,5-Cl(H2N)C6H3CO2H, 152.5-4.5° (from iso-PrOH), D, 0, 0.6, >1200, 110; 3,4-Cl(H2N)C6H3CO2H, 148-50° (from EtOH-EtOAc), A, 1.2, 0.7, >450, 45; II, 170-1° (from EtOH), A, -, -, -, -; III, 154-5.5° (from EtOH-EtOAc), D, 2.8, 3.5, 130, 31; 3,5,4-Cl2(H2N)C6H2CO2H, 237-8° (from EtOH), A, 0.7, 2.0, 290, 44. The EtMeCHNH(CH2)2 ester HCl salts of the following acids (same data given): 2,5-Cl(O2N)C6H3CO2H, 158.5-9.5° (from EtOH), C, -, -, -, -; 2,5-Cl(H2N)C6H3CO2H, 121-3° (from iso-PrOH), D, 0, 2.0, >1200, 75; 3,4-Cl(O2N)C6H3CO2H, 174-5° (from EtOH), C, -, -, -, -; 3,4-Cl(H2N)C6H3CO2H HCO2H salt, 108-9° (from EtOH-EtOAc), D, 0.8, 1.5, 490, 45; 4,3-Cl(O2N)C6H3CO2H, 185-7° (from EtOH), C, -, -, -, -; 4,3-Cl(H2N)C6H3CO2H, 179-80.5°, D, 0.3, 2.0, 570, 68. The amino alc. in the preparation of IV neutralized incompletely gave N-[2-(2-chloro-4-nitrobenzoxy)-1-propyl]-N-cyclohexyl-2-chloro-4-nitrobenzamide) cream-colored solid, m. 156.5-58° (from CHCl3-Et2O) as a by-product. 2,4-(O2N)2C6H3CO2(CH2)2NEt2 (0.6 g.) in 20 cc. EtOH and 1 cc. 3N NH4OH treated at room temperature 0.5 hr. with H2S, the mixture filtered, and the filtrate concentrated gave 0.2 g. 4,2-HONH(O2N)C6H3CO2(CH2)2NEt2, m. 170-2° (from EtOH) having topical activity 0, intradermal activity 0.5, subcutaneous LD50 790, and intravenous LD50 55.
Journal of the American Chemical Society published new progress about 5204-46-6. 5204-46-6 belongs to chlorides-buliding-blocks, auxiliary class Chloride,Carboxylic acid,Amine,Benzene, name is 4-Amino-2,6-dichlorobenzoic acid, and the molecular formula is C7H5Cl2NO2, Computed Properties of 5204-46-6.
Referemce:
https://en.wikipedia.org/wiki/Chloride,
Chlorides – an overview | ScienceDirect Topics